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 P
ruritus is the subjective sensation 
of itching. It can become severe 
enough to interfere with work and 
restful sleep. Histamine is the pri-
mary mediator of itching in many disorders.1 
Antihistamines are effective in treating 
histamine-mediated pruritus, but they 
may be less effective in patients with dis-
eases that trigger pruritus through mecha-
nisms involving serotonin, leukotrienes, or 
neuropeptides.1,2
Evaluation
The initial clinical approach in patients 
with pruritus includes a history and physi-
cal examination to determine if the pruritus 
is caused by a dermatologic condition or is 
secondary to an underlying systemic dis-
ease. Figure 1 is a diagnostic algorithm for 
pruritus.
The presence of a primary skin lesion may 
aim the evaluation toward a dermatologic 
cause. The history should focus on recent 
exposures to new topical, oral, or airborne 
substances that can cause skin lesions. New 
cosmetics and creams can trigger allergic 
contact dermatitis, urticaria, and photo-
dermatitis. New drugs (medications, nutri-
tional supplements, illicit drugs) can lead to 
urticaria or fixed drug eruptions. Travel can 
expose a person to new foods that can trig-
ger urticaria and to sunlight that can trigger 
photodermatitis. Travelers are also suscep-
tible to infestations, such as with scabies or 
lice. Hobbies may expose the skin to solvents 
and topical agents that can trigger contact 
dermatitis. Chronic occupational exposure 
to solvents can dry the skin, causing xerosis 
and atopic dermatitis or eczema. New ani-
mal exposures can lead to flea infestations, 
allergic cutaneous reactions to dander, and 
urticaria. Another important finding in 
the evaluation of patients with pruritus is a 
recent exposure to sick contacts who have 
febrile diseases, such as rubeola, mumps, or 
varicella, or exposure to infectious organisms 
that can cause rashes, such as parvovirus, 
Staphylococcus aureus, or Streptococcus 
Pruritus can be a symptom of a distinct dermatologic condition or of an occult underlying 
systemic disease. Of the patients referred to a dermatologist for generalized pruritus with no 
apparent primary cutaneous cause, 14 to 24 percent have a systemic etiology. In the absence of 
a primary skin lesion, the review of systems should include evaluation for thyroid disorders, 
lymphoma, kidney and liver diseases, and diabetes mellitus. Findings suggestive of less seri-
ous etiologies include younger age, localized symptoms, acute onset, involvement limited to 
exposed areas, and a clear association with a sick contact or recent travel. Chronic or general-
ized pruritus, older age, and abnormal physical findings should increase concern for underly-
ing systemic conditions. Initial evaluation for systemic disease includes complete blood count 
and measurement of thyroid-stimulating hormone, fasting glucose, alkaline phosphatase, bili-
rubin, creatinine, and blood urea nitrogen. Hodgkin lymphoma is the malignant disease most 
strongly associated with pruritus, which affects up to 30 percent of patients with the disease. 
Chest radiography is needed when lymphoma is suspected. A wheal and flare response indi-
cates histamine-induced pruritus in patients with urticaria or an allergic dermatitis. These 
patients benefit from continuous dosing of a long-acting antihistamine. Second-generation 
antihistamines, such as cetirizine, loratadine, and fexofenadine, may be more effective because 
of improved patient compliance. (Am Fam Physician. 2011;84(2):195-202. Copyright © 2011 
American Academy of Family Physicians.)
▲
 Patient information: 
A handout on pruritus, 
written by the authors of 
this article, is provided on 
page 203.
Pruritus
196  American Family Physician www.aafp.org/afp Volume 84, Number 2 ◆ July 15, 2011
species. In the absence of a primary skin 
lesion, the review of systems should include 
evaluation for thyroid disorders, lymphoma, 
kidney and liver diseases, and diabetes mel-
litus. Table 1 includes historical findings that 
suggest etiologies for pruritus.
Physical examination should include an 
evaluation of the liver, spleen, and lymph 
nodes. Organomegaly increases the likeli-
hood of an underlying systemic disease, such 
as lymphoma. The skin should also be exam-
ined. Finger webs, intertriginous regions, 
and the genitals should be evaluated for the 
presence of scabies or lice.
Historical and physical findings that sug-
gest a less serious etiology include younger 
age, localized symptoms, acute onset, 
involvement limited to exposed areas, and a 
clear association with a sick contact or recent 
travel.3-5 Chronic or generalized pruritus, 
age older than 65 years, and abnormal physi-
cal findings should increase concern for an 
underlying systemic condition.3-8
If the diagnosis is unclear after the his-
tory and physical examination or if initial 
empiric treatment is ineffective, a limited 
laboratory evaluation should be performed, 
including complete blood count and mea-
surement of thyroid-stimulating hormone, 
fasting glucose, alkaline phosphatase, bili-
rubin, creatinine, and blood urea nitrogen.5 
If immune suppression or lymphoma is 
possible, a human immunodeficiency virus 
antibody assay and chest radiography should 
also be performed.5-8 Further diagnostic 
tests may include biopsy, scraping, or culture 
of the skin or lesions.
Differential Diagnosis of Pruritus
Pruritus can be a symptom of a distinct der-
matologic condition (Table 2 7) or of an occult 
underlying systemic disease (Table 3 2,3,5,7,9,10). 
COMMON DERMATOLOGIC CAUSES
Atopic Dermatitis. Atopic dermatitis is char-
acterized by pruritus. It is generally defined 
as a chronic, relapsing inflammatory skin 
disease that often occurs in patients with 
a personal or family history of asthma or 
allergic rhinitis.11 In contrast to other der-
matologic disorders, atopic dermatitis often 
lacks a primary skin lesion. Usually only the 
secondary cutaneous findings of excoria-
tion, weeping, lichenification, and pigment 
changes are apparent.2
Contact Dermatitis. Contact dermatitis 
is a rash caused by direct skin exposure to 
Diagnosing the Cause of Pruritus
Figure 1. Diagnostic algorithm for pruritus.
History and 
examination suggest 
underlying diagnosis?
Treat Perform initial testing: 
Complete blood count
Measurement of fasting 
glucose, creatinine, 
blood urea nitrogen, 
thyroid-stimulating 
hormone, bilirubin, and 
alkaline phosphatase
Consider the following tests if 
systemic condition is suspected (e.g., 
age older than 65 years, generalized 
pruritus, chronic pruritus [three 
weeks], abnormal physical findings): 
Human immunodeficiency virus 
antibody assay
Chest radiography
Patient presents with pruritus
Perform history with review of systems, 
and focused physical examination
Primary skin lesion is identifiable?
Yes No
Yes No
Diagnosis established?
Treat
Yes No
Yes No
Treat Referral
Consider additional diagnostic 
testing (skin or lesion):
Biopsy
Scraping (potassium hydroxide 
[KOH], mineral oil)
Culture (bacterial, viral, fungal)
Diagnosis established?
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a substance. It is one of the most common 
skin disorders, with a lifetime prevalence 
of 30 percent.12 Often intensely pruritic, the 
dermatitis can be induced by an allergen or 
more commonly by an irritant. Irritant con-
tact dermatitis represents the most common 
cause of occupational skin diseases in indus-
trial countries.13
Dermatophytes. Dermatophyte infections 
cause localized pruritus and a rash char-
acterized by peripheral scaling and central 
clearing. Tinea pedis (athlete’s foot) usually 
occurs between the toes with dry, cracking 
skin and white areas of maceration. Tinea 
infections can occur at several other sites, 
including the scalp, trunk, and groin.
Lice. Pediculosis is marked by pruritus 
caused by a delayed hypersensitivity reac-
tion to the saliva of the louse. A magnify-
ing lens is often necessary to see the lice or 
eggs, usually at the base of hair shafts. Body 
lice are typically found in patients with poor 
hygiene, whereas pubic lice are sexually 
transmitted.14
Lichen Simplex Chronicus. Lichen simplex 
chronicus is a localized disorder charac-
terized by pruritus that leads to thickened, 
lichenified, violaceous patches. These 
patches are intensely pruritic, which causes 
the patient to continue to scratch, perpetu-
ating the cycle. Early lesions manifest as 
erythematous, well-defined plaques with 
excoriations. Lesions continue to thicken if 
the itch-scratch-itch cycle is not broken with 
appropriate treatment.15
Psoriasis. Up to 80 percent of patients with 
psoriasis report pruritus that is cyclical, with 
nocturnal exacerbations that interrupt sleep. 
Pruritus is often more generalized and not 
restricted to areas of psoriatic plaques.16
Scabies. The classic feature of scabies is 
pruritus, which is caused by deposition of 
mite eggs in the epidermal layer of skin. The 
pruritus is often severe and worsens at night. 
Table 1. Historical Findings That Suggest Etiologies  
for Pruritus
Historical finding Possible etiologies
New cosmetics or creams Allergic contact dermatitis, 
urticaria, photodermatitis
New medications, supplements,  
or illicit drugs 
Urticaria, fixed drug eruptions
Recent travel Pediculosis, scabies infestation, 
photodermatitis, urticaria 
Hobby or occupational exposure  
to solvents, adhesives, cleaners
Irritant contact dermatitis, xerosis, 
atopic dermatitis, eczema
New animal exposures Flea infestation, allergic contact 
dermatitis, urticaria
Sick contacts, especially those with 
febrile diseases and rashes
Rubeola, mumps, varicella, scarlet 
fever, cellulitis, fifth disease, 
folliculitis
Unexplained weight changes, 
menstrual irregularity, heat/cold 
intolerance
Thyroid disease with secondary 
urticaria or xerosis
Unexplained weight loss, night 
sweats, unexplained fevers, fatigue
Lymphoma with secondary 
generalized pruritus
Malaise, nausea, decreased urine 
output
Renal failure with generalized 
pruritus 
SORT: KEY RECOMMENDATIONS FOR PRACTICE
Clinical recommendations
Evidence 
rating References
If there is diagnostic uncertainty in patients with pruritus, initial 
evaluation for systemic disease should include thyroid-stimulating 
hormone, fasting glucose, alkaline phosphatase, bilirubin, creatinine, 
and blood urea nitrogen levels; complete blood count; and human 
immunodeficiency virus antibody assay.
C 6-8
First- and second-generation antihistamines are equally effective for 
resolution of pruritus.
B 39
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evi-
dence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information 
about the SORT evidence rating system, go to http://www.aafp.org/afpsort.xml.
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The primary lesion is a small, erythema-
tous papule that is often excoriated. A thin, 
reddish-brown line, or burrow, 2 to 15 mm 
long in intertriginous regions is more patho-
gnomic. However, burrows are often absent 
or obscured by excoriation or secondary 
infection.17
Urticaria. Urticaria, or hives, is a common 
disorder that affects up to 25 percent of the 
population.18 The usual lesion is an intensely 
pruritic, well-circumscribed, erythema-
tous, elevated wheal. Individual lesions may 
coalesce and wax and wane over several 
hours.19 Histamine is the primary mediator 
Table 2. Dermatologic Etiologies for Pruritus
Etiology Features
Allergic/irritant 
contact dermatitis 
Sharply demarcated, erythematous lesion with overlying vesicles
Reaction within two to seven days of exposure
Atopic dermatitis Pruritic area where rash appears when scratched in patients with atopic 
conditions (e.g., allergic rhinitis, asthma)
Involvement of flexor wrists and ankles, as well as antecubital and  
popliteal fossae
Bullous pemphigoid Initially pruritic urticarial lesions, often in intertriginous areas
Formation of tense blisters after urticaria
Cutaneous T-cell 
lymphoma (mycosis 
fungoides)
Oval eczematous patch on skin with no sun exposure (e.g., buttocks)
Possible presentation of new eczematous dermatitis in older adults
Possible presentation of erythroderma (exfoliative dermatitis)
Dermatitis 
herpetiformis
Rare vesicular dermatitis affecting the lumbosacral spine, elbows, or knees
Dermatophyte 
infection
Localized pruritus and rash characterized by peripheral scaling and central 
clearing
Can occur on several sites, including the feet, scalp, trunk, and groin
Folliculitis Pruritus out of proportion to appearance of dermatitis
Papules and pustules at follicular sites on chest, back, or thigh
Lichen planus Lesions often located on the flexor wrists
Characterized by the six P’s (pruritus, polygonal, planar, purple, papules, 
plaques)
Lichen simplex 
chronicus
Localized, intense pruritus
Initial erythematous, well-defined plaques with excoriations lead to 
thickened, lichenified, violaceous patches if scratching continues
Pediculosis (lice 
infestation)
Occiput in school-aged children; genitalia in adults (sexually transmitted)
Psoriasis Plaques on extensor extremities, low back, palms, soles, and scalp
Scabies Burrows in hand web spaces, axillae, and genitalia
Hyperkeratotic plaques, pruritic papules or scales
Face and scalp affected in children but not in adults
Sunburn Possible photosensitizing cause (e.g., with use of nonsteroidal anti-
inflammatory drugs or cosmetics)
Urticaria (hives) Intensely pruritic, well-circumscribed, erythematous, and elevated wheals
Lesions may coalesce and wax and wane over several hours
Xerosis Intense pruritus, often during winter months in northern climates
Involvement of back, flank, abdomen, waist, and lower extremities
More common in older persons
Adapted with permission from Moses S. Pruritus. Am Fam Physician. 2003;68(6):1136.
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for most types of urticaria, although other 
immunohistochemicals may play an impor-
tant role in more chronic cases.18
Xerosis. Xerosis is the most common cause 
of pruritus in the absence of an identifiable 
skin lesion. It is characterized by dry, scaly 
skin, usually on the lower extremities and in 
axillary creases, and most often occurs in the 
winter months. Associated factors include 
older age, frequent bathing, use of hot water 
when bathing, and exposure to high ambient 
temperatures with relatively low humidity.20
COMMON SYSTEMIC CAUSES
Pruritus in the absence of a primary derma-
tologic etiology may be indicative of a seri-
ous underlying systemic disease.4 Studies 
have shown that 14 to 24 percent of patients 
presenting to a dermatologist’s office with 
pruritus and no primary dermatologic cause 
have a systemic condition.4,9,21-24 However, 
pruritus is often overemphasized as an early 
manifestation of cancer.4,21
Chronic Renal Disease. More than 50 per-
cent of patients with chronic renal disease 
and up to 80 percent of patients on dialysis 
have pruritus.2 The pruritus is often general-
ized, but may be localized to the back.25 
Liver Disease. Pruritus caused by impaired 
bile secretion is a common symptom in sev-
eral forms of liver disease. It can be gener-
alized, but is typically worse on the palms 
and soles. Associated conditions include 
primary biliary cirrhosis, sclerosing cholan-
gitis, viral hepatitis, drug-induced cholesta-
sis, and other causes of obstructive jaundice. 
Biliary obstruction leads to pruritus in 
these disorders, but there is little correlation 
between serum bilirubin level and severity of 
pruritus.26
Malignancy. The possibility of an under-
lying malignant disease should be consid-
ered in patients with generalized pruritus of 
unknown cause. Among malignant diseases, 
Hodgkin lymphoma has the strongest asso-
ciation with pruritus, which occurs in up to 
30 percent of patients with the disease.10 Pru-
ritus can precede the clinical presentation of 
lymphoma by up to five years and is often 
the presenting symptom.5 Pruritus has been 
reported as a paraneoplastic manifestation in 
patients with nasopharynx, prostate, stom-
ach, breast, brain, uterine, or colon cancer.5,27 
Peripheral or Central Nervous System. Pru-
ritus can also arise from diseases or disorders 
of the peripheral or central nervous system, 
such as multiple sclerosis, neuropathy, and 
nerve compression or irritation (e.g., notalgia 
paresthetica, brachioradial pruritus).28
Pregnancy. Pregnancy-related dermatoses 
(Table 4 1-7,29-35) represent a heterogeneous 
group of pruritic inflammatory skin diseases 
related to pregnancy or the postpartum 
period. Some dermatoses cause only intense 
pruritus and skin lesions (e.g., polymorphic 
eruption of pregnancy, atopic eruption of 
pregnancy), but others can cause significant 
fetal risks, including prematurity, growth 
restriction, fetal distress, and intrauterine 
fetal demise (e.g., intrahepatic cholestasis 
of pregnancy, pemphigoid gestationis).29-37 
Table 3. Systemic Etiologies for Pruritus
Autoimmune
Dermatitis herpetiformis 
Dermatomyositis
Linear immunoglobulin A disease
Sjögren syndrome
Hematologic
Hemochromatosis
Iron deficiency anemia
Mastocytosis
Plasma cell dyscrasias
Polycythemia vera
Hepatobiliary 
Biliary cirrhosis
Chronic pancreatitis with obstruction  
of biliary tracts
Drug-induced cholestasis
Hepatitis, particularly hepatitis C
Sclerosing cholangitis
Infectious disease
AIDS
Infectious hepatitis
Parasitic disease (giardiasis, onchocerciasis, 
schistosomiasis, ascariasis)
Prion disease
Malignancy
Leukemia
Lymphoma
Multiple myeloma
Solid tumors with 
paraneoplastic syndrome
Metabolic and endocrine
Carcinoid syndrome
Chronic renal disease
Diabetes mellitus
Hyper/hypothyroidism
Hyperparathyroidism
Neurologic
Cerebral abscess
Cerebral tumor
Multiple sclerosis
Stroke
Other
Drug ingestion
Eating disorders with rapid 
weight loss
Neuropsychiatric disorders
Pregnancy
Information from references 2, 3, 5, 7, 9, and 10.
Pruritus
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Early recognition, precise diagnosis, and 
prompt treatment are essential for improv-
ing maternal and fetal prognosis.
Psychiatric Illness. Psychiatric illness can 
cause pruritus and is diagnosed through 
exclusion. Neurotic excoriations are scat-
tered, linear, crusted lines that may occur 
anywhere on the body within reach of the 
patient, although they are most often con-
fined to the extremities. They are associated 
with obsessive-compulsive disorder, depres-
sion, and delusions of parasitosis.38
Treatment
A wheal and flare response is a marker of 
histamine-induced pruritus in patients with 
urticaria or an allergic dermatitis. These 
patients benefit from continuous dosing of 
long-acting antihistamines. First- and second- 
generation antihistamines are equally effec-
tive for resolution of pruritus.39 However, 
second-generation antihistamines (e.g., cetir- 
izine [Zyrtec], loratadine [Claritin], fexo- 
fenadine [Allegra]) cause fewer adverse 
effects, leading to improved patient compli-
ance.2,40 Concurrent administration of hista-
mine H
1
 and H
2
 blockers increases therapeutic 
effectiveness.2
Most patients with pruritus benefit from 
several basic measures to lessen drying of 
skin, which can increase symptoms. Bath-
ing should be limited to short, cool showers 
with soap applied only to intertriginous or 
oily skin areas. A mild moisturizing cream 
should be applied immediately after bathing. 
The patient’s home should be humidified to 
at least 40 percent, especially during dry, 
cold winter months. Contact irritants, such 
as wool, fiberglass, and detergents, irritate 
most skin and can exacerbate symptoms, 
particularly in persons with sensitivity to 
these agents.2,3,5,41,42
Table 4. Pregnancy-Related Dermatoses That Cause Pruritus
Condition Synonyms Timing Features  Important considerations Prognosis
Atopic 
eruption of 
pregnancy 
Prurigo, early-onset prurigo, 
pruritic folliculitis, or eczema of 
pregnancy; prurigo gestationis
Second trimester (75 percent 
of patients affected before 
third trimester)
Tends to recur in subsequent 
pregnancies
Two-thirds of patients have widespread 
eczematous changes, mainly on flexural 
sites1,2
One-third of patients have focal lesions; 
follicular, papular, or pustular 
Generalized xerosis 
 Most common dermatosis in pregnancy
Affects patients with personal or family history 
of atopy5
Good maternal response to treatment
No fetal effects or lesions
Newborn at high risk of developing atopy
Intrahepatic 
cholestasis of 
pregnancy1,2
Cholestasis of pregnancy, obstetric 
cholestasis, jaundice of pregnancy, 
pruritus gravidarum, prurigo 
gravidarum, icterus gravidarum 
Third trimester
Tends to recur in subsequent 
pregnancies
Sudden onset of intense pruritus
Often starts on palms or soles, then 
becomes generalized
Only secondary skin changes from 
scratching are apparent 
 Elevated total serum bile acid levels Fetal risks include prematurity (19 to 60 percent), 
intrapartum fetal distress (22 to 33 percent),  
and fetal demise (1 to 2 percent)6,7
Close monitoring with delivery after lungs mature 
reduces fetal risks 
Maternal risks include steatorrhea with vitamin K 
deficiency and bleeding complications
Pemphigoid 
gestationis 
Herpes gestationis Third trimester or postpartum
Tends to recur in subsequent 
pregnancies
Intense pruritus precedes urticarial plaques 
or papules surrounding umbilicus
Spreads rapidly and forms bullae
Autoimmune disorder with increased lifetime 
risk of Graves disease
Skin biopsy is needed to confirm diagnosis
Risk of fetal growth restriction3
Antepartum fetal testing is warranted
Causes lesions in 10 percent of newborns 
Polymorphic 
eruption of 
pregnancy 
Pruritic urticarial papules and 
plaques, polymorphic eruption, 
toxic erythema, toxemic rash, or 
late-onset prurigo of pregnancy
Late third trimester and 
postpartum, most often in 
primigravida
Does not tend to recur in 
subsequent pregnancies
Mainly papulourticarial
Starts within striae, coalesces into plaques, 
and spreads to buttocks and proximal 
thighs; spares umbilical region
 Occurs in one in 160 pregnancies4
Typically resolves within four to six weeks5
Associated with excessive maternal weight 
gain and multiple gestation6
Excellent maternal and fetal prognoses
No cutaneous involvement in newborn
Information from references 1 through 7, and 29 through 35.
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The conditions that can lead to pruritus 
are extensive. Distinguishing between pru-
ritus with a specific dermatologic cause and 
pruritus that is a manifestation of a systemic 
disease can facilitate efficient diagnosis and 
treatment, leading to a rapid resolution of 
symptoms for most patients. Treatment 
options for specific etiologies of pruritus are 
beyond the scope of this article.
The opinions and assertions contained herein are the 
private views of the authors and are not to be construed 
as official or as reflecting the views of the U.S. Air Force 
Medical Department or the U.S. Air Force at large.
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